Tonix Pharmaceuticals Holding Corp. (TNXP)
13.72
-0.26
(-1.86%)
USD |
NASDAQ |
Mar 05, 16:00
13.66
-0.06
(-0.44%)
Pre-Market: 08:27
Tonix Pharmaceuticals Cash from Investing (TTM) : -3.687M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amgen, Inc. | -1.943B |
| Amicus Therapeutics, Inc. | -46.43M |
| Soligenix, Inc. | -0.0039M |
| Citius Oncology, Inc. | -10.19M |
| ACADIA Pharmaceuticals, Inc. | -302.56M |